News

Article

Accord Healthcare Inc. Recalls Hydrochlorothiazide Tablets USP 12.5 Mg

The company is voluntarily recalling one lot of Hydrochlorothiazide Tablets USP 12.5 Mg because of a labeling mix-up.

On Aug. 27, 2018, Accord Healthcare Inc. announced it was voluntarily recalling one lot of Hydrochlorothiazide Tablets USP, 12.5 mg. The recall was initiated after a pharmacy complained that a 100-count bottle of Hydrochlorothiazide Tablets USP 12.5 mg contained 100 Spironolactone Tablets USP 25 mg instead. After preliminary and interim investigations, the company believes no other lots of Hydrochlorothiazide Tablets are affected.

Hydrochlorothiazide tablets are used to manage hypertension either alone or with other antihypertensive drugs. Spironolactone tablets are used to treat primary hyperaldosteronism, edematous conditions for patients with congestive heart failure, cirrhosis of the liver accompanied by edema and/or ascites, nephrotic syndrome, essential hypertension, hypokalemia, and severe heart failure. According to the company, “use of spironolactone tablets instead of hydrochlorothiazide tablets poses the risk of contracting hyperkalemia (increase potassium levels) in certain individuals, resulting in adverse events that range from limited health consequences to life-threatening situations in certain individuals.”

Accord stated in a press release that it has not received any reports of adverse events. Adverse events may be reported to FDA through its MedWatch program.

Source: FDA

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content